The Maltese Authority for the Responsible Use of Cannabis (ARUC) has announced the criteria for opening a cannabis club.
Proposals for the introduction of a regulated cannabis market are expected by the end of March.
The company has been granted a licence for the production of high-THC active pharmaceutical ingredients (APIs) by Swissmedic.
The new facility will ‘improve security of supply’ and meet demand from patients across Europe.
Regular consumers reported fewer health issues and used less prescription medications.
Draft regulations for the legalisation of medicinal cannabis in Spain are expected any day.
The French Council of State ruled that sale of CBD in leaf and flower form does not pose a risk to public health.
Experts predict what the year ahead could hold for cannabis consumers across Europe and beyond.
From groundbreaking studies to patient perspectives, here’s what happened in the world of UK cannabis (and beyond) in 2022
Does Malta’s medical cannabis model favour industry profit over patient needs?